IMPATH Inc.

IMPATH, Inc. (IMPATH) is a privately held cancer information services company. It is principally engaged in providing cancer testing and analysis on an outsourcing basis. The company offers diagnostic and prognostic information to hospitals, medical centers, clinical laboratories and physicians. IMPATH focuses on the clinical application of advanced technologies to enable clinicians make better treatment decisions for their cancer patients. It conducts analysis by utilizing immunohistochemistry, molecular pathology, micrometastases detection and serum analysis technologies. In addition, the company also offers monoclonal antibody and molecular probe characterization services and global medical research network. Further, it licenses tumor registry software. IMPATH is headquartered in New York, the US.

Street: 
521 West 57th Street
City: 
New York
Postcode: 
10019
Federal State : 
United States
WebSite: 
www.impath.com
Fax: 
1-212-6980305

Company Index Score

Current Index Score Historical Index Score
  • IMPATH Inc. currently scores 50 % in the index.
  • IMPATH Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • IMPATH Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets